3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Breast
1
Conditions
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
Paclitaxel
162
Fulvestrant
155
Trastuzumab
154
pembrolizumab
144
Letrozole
136
Carboplatin
118
pertuzumab
104
Cyclophosphamide
102
Capecitabine
101
Specimen Handling
100
Anastrozole
90
palbociclib
85
abemaciclib
81
Magnetic Resonance Spectroscopy
81
exemestane
76
Tamoxifen
75
Docetaxel
75
ribociclib
74
trastuzumab deruxtecan
69
Radiotherapy
62
Biopsy
60
Surveys and Questionnaires
56
Gemcitabine
52
130-nm albumin-bound paclitaxel
52
sacituzumab govitecan
50
olaparib
50
Standard of Care
50
Blood Specimen Collection
50
Taxes
47
Doxorubicin
46
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Association
×
Breast
×
1 year
×
Clear all
NCT01613482
2026-03-16
TSARINE
Centre Oscar Lambret
Phase 3
Terminated
13 enrolled